Florida surgeon general, Joseph Ladapo, says Biden admin ‘actively preventing’ monoclonal antibody treatments

Florida Surgeon General Joseph Ladapo accused the Biden administration of “actively preventing the effective distribution of monoclonal antibody treatments” in the United States, according to a Tuesday letter addressed to Secretary of Health and Human Services Xavier Becerra.

The Biden administration recently paused shipments of COVID-19 antibody treatments manufactured by major drug companies Regeneron and Eli Lilly amid claims that such treatments are not effective against the omicron variant of the coronavirus.

The federal government continues to supply Sotrovimab, a monoclonal antibody from the company Glaxosmithkline, which reportedly does work against omicron.

Ladapo concluded his letter by referencing comments Biden made Monday that there wasn’t a solution by the federal government to end the nearly two-year-old pandemic.

“There is no federal solution. This gets solved at the state level,” Biden said at the time in response to Arkansas Republican Gov. Asa Hutchinson warning the president against letting “federal solutions stand in the way of state solutions.”

Ladapo concluded his letter by referencing comments Biden made Monday that there wasn’t a solution by the federal government to end the nearly two-year-old pandemic.

“There is no federal solution. This gets solved at the state level,” Biden said at the time in response to Arkansas Republican Gov. Asa Hutchinson warning the president against letting “federal solutions stand in the way of state solutions.”